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There is growing recognition that assessment of heart valve disease in a resting 
state provides an incomplete evaluation of valve haemodynamics as the severity of valve 
obstruction and regurgitation is dynamic. Changes in flow and alterations in afterload, 
pre-load and heart rate during both pharmacological stress and exercise can change the 
valve haemodynamics. In low flow states, incrementing stroke volume may reveal the true 
severity of aortic stenosis. Alterations in opening and closing forces on the mitral valve 
with exercise alters the degree of mitral regurgitation/stenosis and may explain the cause 
of symptoms in patients with only mild regurgitation/stenosis at rest. This review examines 
the role of stress echocardiography in heart valve disease focussing on the 
pathophysiology of changes in valve haemodynamics during stress echocardiography 
and how these can be used to improve our quantification of valve disease, explain 
symptoms and aid decision making for valve intervention and follow-up. 
AORTIC STENOSIS 
Aortic stenosis is the most common left sided valve lesion [1] and affects more 
than 10% of individuals over the age of 75 [2]. Symptomatic severe aortic stenosis or low-
gradient aortic stenosis with reduced ejection fraction and evidence of contractile reserve 
are Class I indications for aortic valve intervention [3,4]. Surgical aortic valve replacement 
is indicated in asymptomatic patients with severe aortic stenosis and left ventricular 
ejection fraction (LVEF) <50% or if symptoms related to aortic stenosis occur on exercise 
testing [3,4]. However, there are many areas where controversy regarding the optimal  
management of patients is debated. These include the management of patients with 
asymptomatic, severe aortic stenosis and the diagnosis and management patients with 
severe aortic stenosis with an aortic valve area <1cm2 but a mean gradient <40mmHg. 
  
Figure 1 provides a diagnostic algorithm for the use of stress echocardiography in aortic 
stenosis. 
ASYMPTOMATIC SEVERE AORTIC STENOSIS 
The timing of intervention in asymptomatic severe aortic stenosis is controversial. 
The clinical course is highly variable with a risk of sudden death (1-1.5% per year) [5,6,7].  
Regular surveillance with six monthly clinical and echocardiographic evaluation is 
currently recommended [3]. Early surgery requires consideration of both the risk of 
surgery and prosthetic valve related complications. Nearly 40% of patients with severe 
aortic stenosis do not report symptoms at the time of diagnosis but limitation is unmasked 
during exercise treadmill testing.  Contrary to previous guidance exercise testing has 
been shown, comprehensively, to be safe in these patients and the results provide 
prognostic information [8,9,10]. Exercise parameters of value include exercise induced 
symptoms, a fall in blood pressure, ST depression and ventricular arrhythmia [8]. A more 
parametric approach including quantification of exercise workload may be useful; Masri 
et al [11] found, in 533 asymptomatic patients with severe aortic stenosis and preserved 
left ventricular ejection fraction undergoing exercise stress echocardiography with 6 year 
follow up, a lower percentage of age-sex-predicted metabolic equivalents (METS) and 
slower heart rate recovery were associated with longer-term mortality.  
Exercise stress echocardiography allows not just the assessment of functional 
capacity and haemodynamic changes but also the measurement of transvalvular gradient 
under higher flow conditions, measurement of left ventricular contractile function and 
estimation of pulmonary artery systolic pressures. In asymptomatic severe aortic 
stenosis, a stiffer, less compliant valve (as evidenced by a significant exercise induced 
  
rise in mean aortic valve gradient of 18-20mmHg) has been demonstrated to be a marker 
of increased likelihood of aortic valve related events during follow-up [12,13]. The 
increase in mean gradient during exercise may reflect either the presence of more severe 
aortic stenosis or a non-compliant rigid valve. Lancellotti et al [14] also identified exercise-
induced pulmonary hypertension occurring in 55% of their cohort of patients with 
asymptomatic severe aortic stenosis and was associated with a two fold increased risk of 
cardiac events.   Although this data has been challenged by Goublaire et al [15]. Among 
148 patients undergoing exercise stress echocardiography, 112 patients had a normal 
exercise test with no symptoms, fall in blood pressure and/or ST segment depression. 
Out of these, 38 patients (34%) exhibited a mean gradient increase >20mmHg and/or 
systolic pulmonary artery pressure (SPAP) >60mmHg at peak exercise. During a mean 
follow up of 14± 8 months, neither a mean gradient increase >20 mmHg nor peak 
SPAP>60mm Hg was predictive of occurrence of aortic stenosis-related events or aortic 
valve replacement.  
An abnormal left ventricular response to exercise (manifest by a lack of increment 
or decrease in LVEF on exercise) is associated with increased likelihood of developing 
symptoms on exercise and lower survival free of cardiac events than those with an 
appropriate increase in LVEF on exercise [16]. However, left ventricular longitudinal strain 
is a more powerful parameter than LVEF to predict the occurrence of symptoms, exercise 
tolerance and cardiac events [17,18]. Huded et al [19], in a study of 504 asymptomatic 
patients with severe aortic stenosis, showed that age and sex predicted METS (hazard 
ratio 1.16), left ventricular global longitudinal strain (hazard ratio 1.12) and valvuloarterial 
impedance (Zva) (hazard ratio 1.25) offered incremental prognostic value. However, at 
  
present no clinically applicable cut-offs for contractile reserve using strain in aortic 
stenosis have been validated.  
All of these studies have included a relative small number of patients and the 
conflicting results mean further research into the significance of valve gradient changes, 
contractile reserve and changes in pulmonary vascular behaviour is required.  Despite 
the lack of conclusive data the objective assessment of the myocardial and valve 
behaviour under stress conditions, especially when combined with objective measures of 
exercise capacity is helpful in the assessment of patients where decision making is 
difficult. 
TEST PROTOCOL 
Performing the test using a semi-supine bicycle is generally the preferred method 
of performing the test, as images can be acquired during exercise, rather than 
immediately after exercise [20]. Baseline images must include an assessment of all left 
ventricular myocardial segments, aortic valve continuous wave Doppler for measurement 
of mean gradient, pulse wave velocity from the left ventricular outflow tract and continuous 
wave doppler across the tricuspid valve for the estimation of PASP.  A 12 lead 
electrocardiogram should be placed to look for ST segment changes and arrhythmia.  
Blood pressure measurements should be made at each stage.  There is no unified and 
excepted protocol however a workload of 25 Watts increasing in 25 Watts increments at 
2 minute intervals is usually recommended. The test is symptom limited and stopped if 
the patient develops dyspnoea, chest pain, dizziness or there are adverse haemodynamic 
changes (reduction in blood pressure, arrhythmia, ST changes). Images should be 
  
acquired at an intermediate heart rate of between 90 and 110 beats per minute as well 
as at peak exercise. 
LOW FLOW, LOW GRADIENT AORTIC STENOSIS 
Severe high-gradient aortic stenosis is conventionally defined as a calculated 
aortic valve area of <1.0 cm2 (or <0.65cm2/m2) corroborated by a peak aortic jet velocity 
of >4.0 m/s and a mean transvalvular pressure gradient of >40 mmHg [21]. The 
classification of aortic stenosis severity is not always so straightforward, and the 
echocardiographic findings are discordant in one in three patients [22,23].  The most 
common being a valve area in the severe range (<1cm2) with a low mean gradient 
(<40 mmHg). Here, the first and most important distinction needs to be made between 
those with low flow (conventionally considered <35 mls/m2) and those with normal flow, 
Amongst the latter in whom measurement inaccuracy is most commonly a source of error 
[21] as well as problems with the assumptions of circularity in the often eccentric LVOT 
and the inherent discrepancy between valve area and gradient [23,24]. 
Once satisfied that the situation is one of low-flow low-gradient (LF-LG), patients 
can be further sub classified into those with a reduced LVEF  (defined as classical low 
flow) or preserved LVEF (termed paradoxical low flow). In the former ventricular systolic 
function is usually the principle cause of the low flow while the latter is more complex with 
a contribution from myocardial geometry (small left ventricular cavity size), ventricular 
long axis dysfunction and augmented afterload. The evidence for classical LFLG is very 
robust whereas the role of stress echo in the latter is much less clear. 
LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS WITH REDUCED EJECTION FRACTION 
  
When the LVEF is reduced It is important to distinguish between true-severe aortic 
stenosis with low flow (where severe aortic stenosis and high afterload are the main 
causes of the reduced flow) and so called pseudo-severe aortic stenosis (mild or 
moderate aortic stenosis with low flow predominantly due to left ventricular myocardial 
disease leading to incomplete aortic valve opening and a reduced valve area) [25,26].  
Dobutamine stress echocardiography (DSE) provides robust data to differentiate 
between these by increasing flow through the valve [25]. By augmenting transvalvular 
flow dobutamine infusion there should be an increase in stroke volume. An increase of 
>20% suggests the presence of flow reserve.  There are three principle outputs from 
Dobutamine stress echo. True-severe aortic stenosis where the typical findings will be an 
unchanged aortic valve area (which remains <1cm2) but a marked increase in mean 
gradient to >40mmHg; pseudo-severe (moderate) AS where there is an increase in valve 
area but relatively little increase in mean gradient [27].   In the third output flow reserve is 
not observed making differentiation between severe and pseudo-severe aortic stenosis 
difficult. One approach presented by the TOPAS study investigators is to calculate a 
projected effective orifice area that would have occurred at a standardised flow rate of 
250 ml/s.  This has the advantage that, while stroke volume does have to increase to 
some extent, an increase in 20% is not required They have shown projected aortic valve 
area is more closely related to actual aortic stenosis severity and a better marker of 
prognosis and than traditional DSE parameters [28, 29].   
The assessment of left ventricular flow reserve during low-dose DSE has clear 
prognostic implications in true severe aortic stenosis [30,31]. If a 20 % increase in stroke 
volume is associated with the development of a mean aortic gradient of 40 mmHg or a 
  
peak velocity of greater than 4 m/s, with an unchanged valve area, then the aortic stenosis 
is severe and intervention is warranted [3,4]. If no flow recruitment is observed then the 
outlook from surgery is very poor, with a high operative risk, and the recommendations 
for aortic valve replacement in these patients is weaker (IIb, level of evidence C) [3,4].   
LOW FLOW LOW GRADIENT AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION 
Paradoxical low-flow low-gradient aortic stenosis occurs in 25-35% of patients with 
low-gradient aortic stenosis [32,33]. It is defined as an aortic valve area <1.0 cm2, indexed 
aortic valve area <0.6 cm2/m2, mean gradient <40 mmHg, LVEF ≥50%, and presence of 
low flow (stroke volume index <35 ml/m2). The low stroke volume is usually caused by a 
small left ventricular cavity related to concentric left ventricular hypertrophy compounded 
by high after load with raised ventricular vascular impedance (Zva). Other causes include 
mitral stenosis and regurgitation, tricuspid regurgitation and atrial fibrillation.  
Approximately, one-third of these patients will have pseudo-severe (moderate) 
aortic stenosis. [34]. DSE (applying the same principles as for classical LF-LG aortic 
stenosis) may have some role in these patients but the evidence of far less robust.  
Furthermore the results may be inconclusive, due to the presence of a restrictive 
myocardial filling. Where DSE is used, the calculation of projected valve area which is 
less dependent on a large increase in stroke volume may be more robust [34]. 
Consequently it is critical to integrate other imaging markers of severity of which aortic 
valve calcium scoring by multi-detector computed tomography has been shown to 
correlate well with the haemodynamic severity of aortic stenosis [35,36].   
  Studies have shown that the outcomes of patients with paradoxical LFLG aortic 
stenosis are better compared with classical LFLG aortic stenosis but worse compared 
  
with high gradient aortic stenosis. However, survival may be markedly improved by aortic 
valve replacement compared with conservative management [37,38].  
Symptomatic patients with paradoxical low-flow, low-gradient aortic stenosis and 
evidence of severe aortic stenosis have a class IIa, level of evidence C, indication for 
aortic valve replacement (ESC/AHA) [3,4]. 
PERFORMING THE TEST 
The low dose dobutamine protocol starts at 5mcg/kg/min and increasing in 
5mcg/kg/min increments every 5 minutes up to a maximum of 20mcg/kg/min. There 
should be less than 10 beat per minute increase in heart rate.  A 12 lead 
electrocardiogram should be placed to look for ST segment changes and arrhythmia.  
Blood pressure measurements should be made at each stage.  The baseline dataset 
comprises aortic valve continuous wave Doppler, left ventricular outflow tract pulsed wave 
Doppler, and views of the left ventricular cavity in apical 4 and 2 chamber positions. These 
parameters should be repeated at each stage. Changes in LVEF, flow reserve (stroke 
volume), peak aortic velocity, mean aortic valve pressure gradient and aortic valve area 
should be calculated [20].  
AORTIC REGURGITATION 
The afterload caused by chronic severe aortic regurgitation leads to an elevated 
left ventricular diastolic pressure and eventual left ventricular dysfunction. Symptomatic 
patients have an increased risk of sudden death. Exercise testing is recommended to 
reveal symptoms and aortic valve replacement is considered a Class I (level of evidence 
  
B) in patients with severe aortic regurgitation and symptoms revealed by exercise testing 
[3,4]. 
Exercise stress echocardiography has no role in the assessment of aortic 
regurgitation severity but can provide an assessment of contractile reserve as well an as 
objective measure of exercise performance in patients with equivocal symptoms. The 
evidence for the indication of stress echo for the assessment of contractile reserve is 
limited. The lack of contractile reserve (<5% change in LVEF) was found to predict left 
ventricular systolic dysfunction development at follow-up in medically managed patients 
and post-operatively in those undergoing aortic valve replacement [39]. Failure to 
increase LVEF at exercise has been found to be specific for predicting left ventricular 
dysfunction, symptom development or sudden death during follow-up [40,41]. 
Measurement of contractile reserve may therefore assist in determining the optimal timing 
of surgery in patients with asymptomatic severe aortic regurgitation, and the absence of 
contractile reserve may identify the presence of subclinical left ventricular dysfunction 
compared to resting echocardiography. Markers of subclinical left ventricular dysfunction 
measured by tissue Doppler imaging and global longitudinal strain can also be measured 
on stress echocardiography [42,43]. 
PERFORMING THE TEST 
The preferred method for image acquisition for exercise echocardiography, is with 
supine or semi-supine bicycle exercise. Resting and exercise image acquisition include 
4 and 2 chamber left ventricular views for calculation of LVEF, estimation of PASP and 
colour flow Doppler to detect mitral regurgitation. The initial workload is 25 Watts and 
  
increased in 25 Watt increments every 2 minutes. The test is symptom limited and 
stopped on development of dyspnoea or fatigue.  
CHRONIC PRIMARY MITRAL REGURGITATION 
Myxomatous degenerative mitral valve (MV) disease is the most prevalent cause 
of primary mitral regurgitation (MR) in developed countries [44,45,46]. Historical data 
suggests prevalence estimates of between 5-15% with associated morbidity and 
cardiovascular risk including stroke, atrial fibrillation, heart failure and the need for MV 
surgery [47,48].  
Both European Society of Cardiology (ESC) and American Heart 
Association/American College of Cardiology (AHA/ACC)  provides recommendations on 
the assessment of MV regurgitation severity and indications for intervention [3,4]. ESC 
guidelines recommend intervention in  symptomatic severe primary regurgitation and 
LVEF ≥ 30% (Class IB). In asymptomatic severe primary regurgitation intervention is 
indicated with evidence of left ventricular dysfunction (left ventricular end-systolic 
diameter (LVESD) ≥45mm and/or LV EF ≤ 60%)  (Class I, B); if LV systolic function is 
preserved (LV EF ≥ 60%, LVESD ≤ 45mm), atrial fibrillation (AF) or pulmonary 
hypertension (estimated PASP > 50mmHg at rest) should prompt consideration of 
intervention  (Class IIa, A). In asymptomatic patients without AF or pulmonary 
hypertension and with preserved LV systolic function (LV EF ≥ 60%, LVESD 40-44mm) 
intervention may be considered  (Class IIa, A), in cases of low surgical risk (<1%) and 
high likelihood of durable repair (>95%), with the presence of ≥1 of: flail leaflet / severe 
left atrial dilatation in sinus rhythm (volume indexed ≥60ml/m2).  
  
In patients with asymptomatic, severe MR, watchful waiting has been considered 
to be a safe strategy, particularly when conducted in a centre with heart valve expertise 
and careful follow up [49]. There are however multiple factors influencing outcomes in 
current trigger-based guidelines. Firstly, the necessity for reliable and reproducible 
echocardiography to enable accurate serial assessment of left ventricularr trigger based 
parameters (LVESD and LVEF). In addition, patient adherence to follow-up and prompt 
reporting of symptoms is important to facilitate timely surgical intervention. Early surgical 
prior to the onset of symptoms is controversial. Although non-randomized registry data 
superior outcomes for early intervention compared to medical management, these studies 
cannot exclude selection bias from their methods [50,51].  
THE ROLE OF STRESS ECHOCARDIOGRAPHY 
Exercise stress echocardiography plays a key role in the assessment of MV 
regurgitation. Stress echocardiography is useful where there is a lack of symptom-
imaging concordance e.g. symptomatic non-severe MR. In addition, it has an important 
role in evaluating exercise capacity, clarifying symptom status and risk stratification in 
patients who appear to be asymptomatic with severe MR. Figure 2 is a algorithm for the 
use of stress echocardiography in patients with primary mitral regurgitation.  
SYMPTOMATIC MILD OR MODERATE MITRAL REGURGITATION 
The concept of dynamic MR where there are significant changes in MR severity 
on exercise is well recognized. Stress echocardiography is useful where symptoms on 
exertion (dyspnoea) are disproportionate to the severity of MR at rest. Tischler et al [52] 
demonstrated up to a third of patients with mild MR could develop severe MR on exertion. 
Therefore exercise stress echocardiography is indicated in patients with dyspnoea on 
  
exertion with no other cause for their symptoms can be identified to exclude dynamic MR. 
ASYMPTOMATIC SEVERE MITRAL REGURGITATION  
  Stress echocardiography with or without cardiopulmonary exercise testing is a 
useful objective test to assess symptom status and exercise capacity in patients who are 
apparently asymptomatic.  In a study of 884 asymptomatic or minimally symptomatic 
patients with significant MR who underwent exercise stress echocardiography, Naji et al 
[53] found 20% of the cohort only achieved <85% age and sex predicted METS [53]. 
Lower percentage METS and heart rate recovery in addition to atrial fibrillation, LVEF and 
right ventricular systolic pressure predicted a composite outcome of death, myocardial 
infarction, stroke and heart failure. In a separate study, Messika-Zeitoun et al [54] 
showed, in patients with good functional capacity (>100% predicted), delayed surgical 
intervention by 1 year had no adverse effect on primary outcomes (mortality, myocardial 
infarction, stroke, and progression to heart failure) and those with reduced (≤100% 
predicted) functional capacity were at higher risk regardless of timing of surgery. Both 
these studies highlight the value of measuring exercise capacity to determine symptom 
status. 
  In addition to exercise capacity, identifying markers of left ventricular impairment 
in patients with normal LVEF is important. Two-dimensional speckle tracking of 
longitudinal myocardial deformation with assessment of global longitudinal strain can 
detect subclinical left ventricular systolic impairment and can be used to assess the 
presence of contractile reserve. Magne et al [55] found the absence of LV contractile 
(defined as an increase in global longitudinal strain of 2% or more) during exercise stress 
echocardiography in patients with preserved left ventricular function was independently 
  
associated with a two-fold increase in risk of cardiac events . Similar results were found 
by Lancellotti et al [56]. In this study, an  average global longitudinal strain > –18.5% and 
a <1.9% change with exercise are predictive of impaired left ventricular systolic function 
following surgery [56]. Impaired global longitudinal strain is predictive of poor cardiac 
outcomes and is associated with all cause mortality; regardless of the presence of left 
ventricular dysfunction, atrial fibrillation, and the type of MV surgery [57].  
Changes in the degree of MR have also been shown to predict future symptom 
onset. In a study of 61 asymptomatic patients with moderate to severe degenerative MR, 
patients with a marked increase in effective regurgitant orifice area during exercise 
(>10mm2) had lower symptom-free survival than those in whom MR decreased or 
remained unchanged [58]. In addition, this group found the development of exercise 
induced pulmonary hypertension (PASP>60mmHg) was associated with significantly 
reduced 2 year survival of 35% compared to 75% in those without exercise induced PASP 
[59]. 
Echocardiographic parameters of right ventricular (RV) systolic function and 
contractile reserve also have value as risk markers for event-free survival in 
asymptomatic significant MR. Exercise-induced RV dysfunction (exercise tricuspid 
annular plane systolic excursion <19 mm) and exercise-induced pulmonary hypertension 
(PASP >54 mm Hg) both convey incremental prognostic value [60].  Post-surgical follow 
up of asymptomatic patients undergoing early surgical repair also demonstrates that 
absence of RV contractile reserve during exercise stress echocardiography predicts lower 
5-year event-free survival rates [61]. The use of tricuspid annular plane systolic excursion 
  
rather than longitudinal RV strain is promoted due to simplicity and reproducibility during 
exercise. 
TEST PROTOCOL 
 Exercise echocardiography can be performed either on a semi-upright bicycle or 
using a treadmill. The advantage of bicycle SE is image acquisition can be performed 
during exercise rather than post-exercise. Baseline images acquired include: left 
ventricular volumes, LVEF, global longitudinal strain, MR quantification both visual 
assessment and quantified using the proximal isovelocity surface area method, PASP. 
For bicycle SE a typical protocol starts with a workload of 25 Watts. The workload is 
increased in 25 Watt increments every 2 minutes. The test is symptom limited. Acquisition 
of images for contractile reserve is performed between a heart rate of 90 – 110bpm prior 
to test cessation.  For treadmill SE, images for contractile reserve are obtained 
immediately post exercise. 
SECONDARY MITRAL REGURGITATION 
ESC guidance on intervention in severe secondary/function MR is more 
conservative reflecting the heterogeneous nature of the pathology and typically advanced 
underlying left ventricular myocardial disease [3]. There is a class II C recommendation 
for surgery with severe secondary MR in the context LVEF >30% and planned coronary 
artery bypass. If the LVEF is <30% then surgery should be considered (class IIa, C) with 
symptoms, an option for revascularization and evidence of myocardial viability. In the 
absence of indication for revascularization, surgery may be considered (IIb, C) if patients 
remain symptomatic despite optimal medical therapy (+/- cardiac resynchronization 
  
therapy) and have a low surgical risk. When surgical risk is not low in this situation then 
a percutaneous edge-to-edge procedure may be considered (IIb, C) with suitable valve 
morphology. If symptomatic with LVEF is <30% then a heart team discussion should 
occur and a percutaneous approach may be considered (IIb, C) following careful 
evaluation for transplant and ventricular assist device. 
In patients with secondary (functional) MR, the role of stress echocardiography is 
evolving. The balance between MV opening and closing forces alters the degree of MR. 
These can be influenced by heart rate, preload and afterload. Therefore, in patients with 
symptoms but only mild or moderate MR exercise stress echocardiography may unmask 
more severe MR on exercise and explain symptoms [62]. This remains the most useful 
role in secondary MR. Exercise SE can quantify contractile reserve (regardless of the 
presence of symptoms), the absence of which is an established risk marker for adverse 
prognosis in non-ischaemic cardiomyopathies [63]. Quantitative changes in MR severity 
assessed by exercise SE provide incremental risk stratification with increased risk of 
cardiac death with increases in effective regurgitant orifice by ≥13 mm2 [64].  At present 
the exact role of these prognostic markers in patient management has not been 
established. 
MITRAL STENOSIS 
The major indication for intervention in mitral stenosis is significant (valve area 
<1.5 cm2) mitral stenosis in the presence of symptoms [3,4]. Exercise testing is useful to 
clarify whether patients with severe mitral stenosis are truly asymptomatic. Stress 
echocardiography useful for haemodynamic assessment of valve severity in patients with 
symptoms which are disproportionate to resting valve severity. 
  
The mitral valve orifice area and trans-mitral gradient is dynamic. Exercise in 
patients with mitral stenosis with restricted mitral valve orifice increases heart rate leading 
to a reduction in diastolic filling time and increase in trans-mitral gradient which in turn 
causes an exponential increase in left atrial and pulmonary capillary pressure [65,66].  In 
addition, left atrial compliance modulates the haemodynamic effect of mitral stenosis on 
the pulmonary vasculature and PASP [67]. These physiological changes explain 
symptom onset on exercise in mitral stenosis quantified as moderate at rest. However, 
left atrial pressure and symptoms of dyspnoea are determined by more than just the 
degree of mitral valve stenosis. Exercise intolerance may often be multifactorial 
particularly in elderly patients. Additional factors include restrictive lung function, 
chronotropic incompetence, limited stroke volume reserve may also play a part and need 
to be considered [66]. 
  Grimaldi et al [68] demonstrated the value of exercise stress 
ehocardiography in patients with moderate mitral stenosis. In symptomatic patients with 
only moderate mitral stenosis, 35 patients (76%) became short of breath. This was 
associated with an increase in mean trans-mitral gradient to at least 15mmHg or 
PASP>60mmHg. An example of exercise-induced gradient and PASP changes in a 
breathless patient with moderate mitral stenosis is provided in figure 3. If the patient is 
unable to exercise, DSE can be used safely. At peak dose dobutamine, a mean mitral 
valve gradient of ≥18mmHg identifies a high risk patient group and can unmask 
haemodynamic significance in up to 40% of those with presumed moderate stenosis [69].  
 The AHA guidelines recommend consideration of percutaneous mitral balloon 
commissurotomy for symptomatic patients with mitral valve area >1.5cm2
 
if there is 
  
evidence of hemodynamically significant mitral stenosis based on pulmonary artery 
wedge pressure greater than 25 mm Hg or mean mitral valve gradient greater than 15 
mm Hg during exercise [4]. The ESC guidelines recommend consideration of 
percutaneous mitral balloon commissurotomy in symptomatic patients with a valve area 
>1.5cm2 if symptoms cannot be explained by another cause and if the anatomy is 
favourable [3].  
TEST PROTOCOL 
 Exercise stress echocardiography is performed on a semi-upright bicycle with a 
starting workload of 25 Watts. The workload is increased in 25 Watt increments every 2 
minutes. The test is symptom limited. Images obtained at rest measure mean MV 
gradient, degree of MR and PASP. Peak images are obtained during exercise when the 
patient becomes symptomatic.  
CONCLUSION 
   Stress echocardiography is an important clinical tool to improve our 
understanding of the significance of valve disease. Stress echocardiography provides 
data in four major domains; the obstructivity / compliance of the valve, changes to 
regurgitant volume, ventricular contractile reserve and the effect on the pulmonary 
vasculature.  In addition to these mechanistic insights it provides an objective measure of 
exercise capacity.  These insights provide additional diagnostic and prognostic 
information to help risk stratify patients and identify the optimal timing of intervention. 
 
 
  
5 YEAR VIEW 
 The current evidence base for stress echocardiography for valve disease is limited 
due to a relative small sample sizes studied. Although there are multiple studies showing 
the prognostic value of stress echocardiography in asymptomatic patients with severe 
valve regurgitation or stenosis, there is a lack of prospectively designed trials examining 
the effect of intervention based on these cut-off on clinical outcomes.  We propose, large, 
multi-centre, international registries to allow further validation of results and define cut-
offs for intervention more rigorously. This would allow testing of this cut-points in 
prospective trials of intervention based on stress echocardiography data.   
 
 
 
 
 
 
 
 
 
 
 
  
 
FIGURES 
Figure 1. Diagnostic Algorithm For The Use Of Stress Echocardiography In Patients With 
Aortic Stenosis. 
Figure 2. Diagnostic Algorithm For The Use Of Stress Echocardiography In Patients With 
Primary Mitral Regurgitation. 
Figure 3. 56 year old patient with rheumatic mitral stenosis who notices they are short of 
breath on exertion. (Panel A + B). Resting mean transmitral gradient 7mmHg and 
pulmonary artery systolic pressure 26mmHg. After 7 minutes exercise the patient 
becomes short of breath. (Panel C + D). There is an increase in mean transmitral mitral 
gradient from 7mmHg to 26mmHg and an increase in pulmonary artery systolic pressure 
from 26mmHg to 82mmHg.  
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